# 3D Systems Corp: Form 10-Q for the period ended Mar 31, 2018

- Company: [3D Systems Corp](/companies/ddd.md) (CIK 910638)
- Form: 10-Q
- Filed: 2018-05-02
- Accepted by EDGAR: May 2, 2018, 16:02 ET
- Period: 2018-03-31
- Accession: 0000910638-18-000011
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/910638/000091063818000011/ddd2018-03x31form10xqdocum.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/910638/000091063818000011/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2018-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2018-01-01 to 2018-03-31 | $88.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2018-01-01 to 2018-03-31 | $77.9m | us-gaap:GrossProfit |
| Research and development | 3 months, 2018-01-01 to 2018-03-31 | $25.9m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2018-01-01 to 2018-03-31 | $69.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2018-01-01 to 2018-03-31 | −$17.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2018-01-01 to 2018-03-31 | $2.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2018-01-01 to 2018-03-31 | −$21.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2018-01-01 to 2018-03-31 | −$0.19 | us-gaap:EarningsPerShareBasicAndDiluted |
| Capital expenditure | 3 months, 2018-01-01 to 2018-03-31 | $10.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2018-03-31 | $121.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2018-03-31 | $439.2m | us-gaap:AssetsCurrent |
| Total assets | at 2018-03-31 | $897.7m | us-gaap:Assets |
| Current liabilities | at 2018-03-31 | $217.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2018-03-31 | $279.5m | us-gaap:Liabilities |
| Shareholders' equity | at 2018-03-31 | $612.2m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 32,525 characters.

This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Item 1 (the “Financial Statements”) of this Quarterly Report on Form 10-Q (“Form 10-Q”). We are subject to a number of risks and uncertainties that may affect our future performance that are discussed in greater detail in the sections entitled “Forward-Looking Statements” at the end of this Item 2 and that are discussed or referred to in Item 1A of Part II of this Form 10-Q.

### Business Overview

3D Systems Corporation (“3D Systems” or the “Company” or “we” or “us”) is a holding company incorporated in Delaware in 1993 that markets our products and services through subsidiaries in North America and South America (collectively referred to as “Americas”), Europe and the Middle East (collectively referred to as “EMEA”) and the Asia Pacific region (“APAC”). We provide comprehensive 3D printing solutions, including 3D printers, materials, software, on demand manufacturing services and digital design tools. Our solutions support advanced applications in a wide range of industries and key verticals including healthcare, aerospace, automotive and durable goods. Our precision healthcare capabilities include simulation, Virtual Surgical Planning (“VSP™”), and printing of medical and dental devices, models, surgical guides and instruments. Our experience and expertise have proven vital to our development of an ecosystem and end-to-end digital workflow which enable customers to optimize product designs, transform workflows, bring innovative products to market and drive new business models.

Customers can use our 3D solutions to design and manufacture complex and unique parts, eliminate expensive tooling, produce parts locally or in small batches and reduce lead times and time to market. A growing number of customers are shifting from prototyping applications to also using 3D printing for production. We believe this shift will be further driven by our continued advancement and innovation of 3D printing solutions that improve durability, repeatability, productivity and total cost of operations.

### Summary of First Quarter 2018 Financial Results

Total consolidated revenue for the quarter ended March 31, 2018 increased by 6.0%, or $9.5 million, to $165.9 million, compared to $156.4 million for the quarter ended March 31, 2017. These results reflect an increase in printers, healthcare and software revenue as well as favorable foreign currency impact, as discussed further below.

Healthcare revenue includes sales of products, materials and services for healthcare-related applications, including simulation, training, planning, 3D printing of anatomical models, surgical guides and instruments and medical and dental devices. For the quarter ended March 31, 2018, healthcare revenue increased by 21.4%, to $52.4 million, and made up 31.6% of total revenue, compared to $43.2 million, or 27.6% of total revenue, for the quarter ended March 31, 2017. The increase in healthcare revenue is driven by growth in products, including printers and materials.

For the quarter ended March 31, 2018, total software revenue from products and services increased 12.9% to $23.0 million, and made up 13.9% of total revenue, compared to $20.4 million, or 13.0% of total revenue for the quarter ended March 31, 2017.

Gross profit for the quarter ended March 31, 2018 decreased by 2.9%, or $2.3 million, to $77.9 million, compared to $80.2 million for the quarter ended March 31, 2017. Gross profit margin for the quarters ended March 31, 2018 and 2017 was 46.9% and 51.3%, respectively.

Operating expenses for the quarter ended March 31, 2018 increased by 6.9%, or $6.1 million, to $95.4 million, compared to $89.3 million for the quarter ended March 31, 2017. Selling, general and administrative expenses for the quarter ended March 31, 2018 increased by 4.7%, or $3.1 million, to $69.5 million, compared to $66.4 million for the quarter ended March 31, 2017, predominantly due to our ongoing investment in go-to-market and IT infrastructure. Research and development expenses for the quarter ended March 31, 2018 increased by 13.3%, or $3.0 million, to $25.9 million, compared to $22.9 million for the quarter ended March 31, 2017, predominantly due to increased research and development, including investments to support our planned 2018 product launches.

Our operating loss for the quarter ended March 31, 2018 was $17.5 million, compared to an operating loss of $9.1 million for the quarter ended March 31, 2017.

For the quarters ended March 31, 2018 and 2017, we used $1.5 million and generated $19.4 million of cash from operations, respectively, as further discussed below. In total, our unrestricted cash balance at March 31, 2018 and December 31, 2017, was $121.6 million and $136.3 million, respectively.

### Results of Operations

#### Comparison of revenue by geographic region

The following table sets forth the change in revenue by geographic region for the quarters ended March 31, 2018 and 2017.

### Table 1

*(Dollars in thousands)*

|  | Americas |  | EMEA |  | Asia Pacific |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — first quarter 2017 | $80,291 | 51.3% | $52,958 | 33.9% | $23,182 | 14.8% | $156,431 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | 6,631 | 8.3% | (511) | (1.0)% | 873 | 3.8% | 6,993 | 4.5% |
| Price/Mix | (2,386) | (3.0)% | (1,949) | (3.7)% | (1,402) | (6.0)% | (5,737) | (3.7)% |
| Foreign currency translation | 11 | —% | 6,918 | 13.1% | 1,272 | 5.5% | 8,201 | 5.2% |
| Net change | 4,256 | 5.3% | 4,458 | 8.4% | 743 | 3.3% | 9,457 | 6.0% |
| Revenue — first quarter 2018 | $84,547 | 51.0% | $57,416 | 34.6% | $23,925 | 14.4% | $165,888 | 100.0% |

Consolidated revenue increased 6.0%, predominantly driven by higher sales volumes in the Americas and APAC regions and the favorable impact of foreign currency in the EMEA and APAC regions, offset by a shift in product mix and average selling price across all geographic regions. The increase in sales volume is due to demand from healthcare and industrial customers. The shift in product mix and average selling price across all geographic regions relates to sales of printer models which carry lower price points.

For the quarters ended March 31, 2018 and 2017, revenue from operations outside the U.S., including Latin America, EMEA and APAC, was 50.1% and 50.2% of total revenue, respectively.

#### Comparison of revenue by class

We earn revenue from the sale of products, materials and services. The products category includes 3D printers, healthcare simulators and digitizers, software licenses, 3D scanners and haptic devices. The materials category includes a wide range of materials to be used with our 3D printers, the majority of which are proprietary, as well as acquired conventional dental materials. The services category includes maintenance contracts and services on 3D printers and simulators, software maintenance, on demand manufacturing solutions and healthcare services. Beginning in 2018, we have classified product warranty revenue and related expenses within products and we have reclassified prior period amounts from services to products to conform to current year presentation.

Due to the relatively high price of certain 3D printers and a corresponding lengthy selling cycle and relatively low unit volume of the higher priced printers in any particular period, a shift in the timing and concentration of orders and shipments from one period to another can affect reported revenue in any given period. Revenue reported in any particular period is also affected by timing of revenue recognition under rules prescribed by U.S. generally accepted accounting principles (“GAAP”).

In addition to changes in sales volumes and the impact of revenue from acquisitions, there are two other primary drivers of changes in revenue from one period to another: (1) the combined effect of changes in product mix and average selling prices, sometimes referred to as price and mix effects, and (2) the impact of fluctuations in foreign currencies. As used in this Management’s Discussion and Analysis, the price and mix effects relate to changes in revenue that are not able to be specifically related to changes in unit volume.

The following table sets forth the change in revenue by class for the quarters ended March 31, 2018 and 2017.

### Table 2

*(Dollars in thousands)*

|  | Products |  | Materials |  | Services |  | Total |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue — first quarter 2017 | $54,216 | 34.6% | $42,823 | 27.4% | $59,392 | 38.0% | $156,431 | 100.0% |
| Change in revenue: |  |  |  |  |  |  |  |  |
| Volume | 8,120 | 15.0% | 292 | 0.7% | (1,419) | (2.4)% | 6,993 | 4.5% |
| Price/Mix | (2,718) | (5.0)% | (3,019) | (7.0)% | — | —% | (5,737) | (3.7)% |
| Foreign currency translation | 3,011 | 5.6% | 2,400 | 5.6% | 2,790 | 4.7% | 8,201 | 5.2% |
| Net change | 8,413 | 15.6% | (327) | (0.7)% | 1,371 | 2.3% | 9,457 | 6.0% |
| Revenue — first quarter 2018 | $62,629 | 37.8% | $42,496 | 25.6% | $60,763 | 36.6% | $165,888 | 100.0% |

Consolidated revenue increased 6.0%, predominantly driven by products revenue and the favorable impact of foreign currency translation, partially offset by a shift in product mix which impacted average selling price for both products and materials.

Products revenue increased due to higher demand from healthcare and industrial customers as well as the favorable impact of foreign currency, offset by changes in product mix which impacted average selling prices from the shift to higher sales of lower priced printers. For the quarters ended March 31, 2018 and 2017, revenue from printers contributed $39.1 million and $31.4 million, respectively. Software revenue included in the products category, including scanners and haptic devices, contributed $12.3 million and $9.8 million for the quarters ended March 31, 2018 and 2017, respectively.

Materials revenue remained relatively flat as the favorable impact of foreign currency was offset by changes in product mix and average selling prices.

Services revenue increased due to the favorable impact of foreign currency translation, partially offset by lower sales volume. For the quarters ended March 31, 2018 and 2017, revenue from on demand manufacturing services contributed $25.7 million and $25.1 million, respectively. For the quarters ended March 31, 2018 and 2017, software services revenue contributed $10.8 million and $10.6 million, respectively.

#### Gross profit and gross profit margins

The following table sets forth gross profit and gross profit margins for the quarters ended March 31, 2018 and 2017.

### Table 3

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2018 Gross Profit | Gross Profit Margin | 2017 Gross Profit | Gross Profit Margin | Change in Gross Profit $% |  | Change in Gross Profit Margin Percentage Points% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Products | 18,319 | 29.3% | 18,093 | 33.4% | 226 | 1.2% | (4.1) | (12.2)% |
| Materials | 31,713 | 74.6% | 31,689 | 74.0% | 24 | 0.1% | 0.6 | 0.8% |
| Services | 27,850 | 45.8% | 30,404 | 51.2% | (2,554) | (8.4)% | (5.4) | (10.5)% |
| Total | $77,882 | 46.9% | $80,186 | 51.3% | $(2,304) | (2.9)% | (4.4) | (8.5)% |

The decrease in total consolidated gross profit is due to mix of sales, particularly in printers, and higher costs in on demand manufacturing.

On demand manufacturing services gross profit margin decreased to 38.8% for the quarter ended March 31, 2018 compared to 43.3% for the quarter ended March 31, 2017.

#### Operating expenses

The following table sets forth the components of operating expenses for the quarters ended March 31, 2018 and 2017.

### Table 4

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2018 Amount | % Revenue | 2017 Amount | % Revenue | Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative expenses | 69,497 | 41.9% | 66,405 | 42.5% | 3,092 | 4.7% |
| Research and development expenses | 25,883 | 15.6% | 22,852 | 14.6% | 3,031 | 13.3% |
| Total operating expenses | $95,380 | 57.5% | $89,257 | 57.1% | $6,123 | 6.9% |

Total operating expenses increased for the quarter ended March 31, 2018 as compared to the quarter ended March 31, 2017 due to both increased selling, general and administrative expenses and research and development expenses. The increase in selling, general and administrative expenses is primarily due to increased marketing and advertising, the implementation of a market-based job architecture and higher bad debt expense and legal expenses. Research and development expenses increased primarily in support of the new products we plan to bring to market throughout 2018 and focused innovation to drive customers’ shift to 3D production, including investment in plastics, metals, materials and software as well as the addition of talent and resources.

#### Loss from operations

The following table sets forth loss from operations by geographic region for the quarters ended March 31, 2018 and 2017.

### Table 5

*(Dollars in thousands)*

| Loss from operations: | Quarter Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Americas | (18,924) | (13,450) |
| EMEA | (2,005) | 533 |
| Asia Pacific | 3,974 | 4,341 |
| Subtotal | (16,955) | (8,576) |
| Intercompany elimination | (543) | (495) |
| Total | $(17,498) | $(9,071) |

The increase in operating loss for the quarter ended March 31, 2018 compared to the quarter ended March 31, 2017 was primarily driven by a decrease in gross profit and an increase in operating expenses. See “*Comparison of revenue by geographic region,” “Gross profit and gross profit margins”* and “*Operating expenses”* above.

#### Interest and other income, net

The following table sets forth the components of interest and other (expense) income, net, for the quarters ended March 31, 2018 and 2017.

### Table 6

*(Dollars in thousands)*

| Interest and other (expense) income, net: | Quarter Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Interest income | 222 | 167 |
| Foreign exchange gain | 61 | 329 |
| Interest expense | (228) | (230) |
| Other expense, net | (1,580) | (65) |
| Total interest and other (expense) income, net | $(1,525) | $201 |

The increase in interest and other (expense) income, net, related to a $1.4 million adjustment to the fair value of certain cost method investments in the first quarter of 2018.

#### Net loss attributable to 3D Systems

The following table sets forth the primary components of net loss attributable to 3D Systems for the quarters ended March 31, 2018 and 2017.

### Table 7

*(Dollars in thousands)*

|  | Quarter Ended March 31, 2018 | 2017 | Change |
| --- | ---: | ---: | ---: |
| Operating loss | $(17,498) | $(9,071) | $(8,427) |
| Other non-operating items: |  |  |  |
| Interest and other (expense) income, net | (1,525) | 201 | (1,726) |
| Provision for income taxes | (1,954) | (1,041) | (913) |
| Net loss | (20,977) | (9,911) | (11,066) |
| Less: net (loss) income attributable to noncontrolling interests | (16) | 60 | (76) |
| Net loss attributable to 3D Systems | $(20,961) | $(9,971) | $(10,990) |
| Net income (loss) per share - basic and diluted | $(0.19) | $(0.09) |  |

The increase in net loss for the quarter ended March 31, 2018 as compared to the quarter ended March 31, 2017 was primarily driven by a decrease in gross profit and an increase in operating expenses. See “*Gross profit and gross profit margins”* and “*Operating expenses”* above.

### Liquidity and Capital Resources

### Table 8

*(Dollars in thousands)*

|  | March 31, 2018 | December 31, 2017 | Change $% |  |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents | $121,607 | $136,344 | $(14,737) | (10.8)% |
| Accounts receivable, net | 134,470 | 129,879 | 4,591 | 3.5% |
| Inventories | 110,383 | 103,903 | 6,480 | 6.2% |
|  | 366,460 | 370,126 | (3,666) |  |
| Less: |  |  |  |  |
| Current portion of capitalized lease obligations | 661 | 644 | 17 | 2.6% |
| Accounts payable | 55,405 | 55,607 | (202) | (0.4)% |
| Accrued and other liabilities | 66,442 | 65,899 | 543 | 0.8% |
|  | 122,508 | 122,150 | 358 |  |
| Operating working capital | $243,952 | $247,976 | $(4,024) | (1.6)% |

We assess our liquidity in terms of our ability to generate cash to fund our operating, investing and financing activities. In doing so, we review and analyze our current cash on hand, the number of days our sales are outstanding, inventory turns, capital expenditure commitments and accounts payable turns. Our cash requirements primarily consist of funding of working capital and funding of capital expenditures.

We believe our existing cash and cash equivalents will be sufficient to satisfy our working capital needs, capital expenditures, outstanding commitments and other liquidity requirements associated with our existing operations in the foreseeable future, or to consummate significant acquisitions of other businesses, assets, products or technologies. However, it is possible that, in the future, we may need to raise additional funds to finance our activities. If needed, we may be able to raise such funds by issuing equity or debt securities to the public or selected investors, by borrowing from financial institutions, drawing down on our credit facility, or selling assets.

Cash held outside the U.S. at March 31, 2018 was $89.4 million, or 73.6% of total cash and equivalents, compared to $88.9 million, or 65.2% of total cash and equivalents at December 31, 2017. As our previously unremitted earnings have been subjected to U.S. federal income tax, we expect any repatriation of these earnings to the U.S. would not incur significant additional taxes related to such amounts. However, our estimates are provisional and subject to further analysis. Cash equivalents are comprised of funds held in money market instruments and are reported at their current carrying value, which approximates fair value due to the short term nature of these instruments. We strive to minimize our credit risk by investing primarily in investment grade, liquid instruments and limit exposure to any one issuer depending upon credit quality. See “*Cash flow”, “Credit facilities”* and “*Capitalized lease obligations”* below.

Days’ sales outstanding was 72 at March 31, 2018 compared to 73 days at December 31, 2017 while accounts receivable more than 90 days past due increased to 9.4% of gross receivables at March 31, 2018, from 9.1% at December 31, 2017. We review specific receivables periodically to determine the appropriate reserve for accounts receivable.

The majority of our inventory consists of finished goods, including products, materials and service parts. Inventory also consists of raw materials and spare parts for the in-house assembly and support service products. We outsource the assembly of certain 3D printers; therefore, we generally do not hold most parts for the assembly of these printers in inventory.

The changes that make up the other components of working capital not discussed above resulted from the ordinary course of business. Differences between the amounts of working capital item changes in the cash flow statement and the balance sheet changes for the corresponding items are primarily the result of foreign currency translation adjustments.

#### Cash flow

The following tables set forth components of cash flow for the quarters ended March 31, 2018 and 2017.

### Table 9

*(Dollars in thousands)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Net cash (used in) provided by operating activities | $(1,539) | $19,388 |
| Net cash used in investing activities | (10,994) | (40,167) |
| Net cash used in financing activities | (3,640) | (4,414) |
| Effect of exchange rate changes on cash | 1,438 | 1,926 |
| Net decrease in cash, cash equivalents and restricted cash | $(14,735) | $(23,267) |

#### Cash flow from operations

### Table 10

*(Dollars in thousands)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Net loss | $(20,977) | $(9,911) |
| Non-cash charges | 23,844 | 21,243 |
| Changes in working capital and all other operating assets | (4,406) | 8,056 |
| Net cash (used in) provided by operating activities | $(1,539) | $19,388 |

Cash used in operating activities for the quarter ended March 31, 2018 was $1.5 million and cash generated by operating activities for the quarter ended March 31, 2017 was $19.4 million. Excluding non-cash charges, net income provided cash of $2.9 million for the three months ended March 31, 2018 and $11.3 million for the three months ended March 31, 2017. Non-cash charges generally consist of depreciation, amortization, and stock-based compensation.

Working capital requirements used cash of $4.4 million for the quarter ended March 31, 2018 and provided $8.1 million for the quarter ended March 31, 2017. In the quarter ended March 31, 2018, cash outflows resulting from increases in accounts receivable, inventory and other current assets were partially offset by an increase in deferred revenues. In the quarter ended March 31, 2017, cash inflows were driven by lower accounts receivable balances combined with an increase in deferred revenues and were partially offset by other working capital items.

#### Cash flow from investing activities

### Table 11

*(Dollars in thousands)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Purchases of property and equipment | $(10,764) | $(5,620) |
| Additions to license and patent costs | (230) | (280) |
| Cash paid for acquisitions, net of cash assumed | — | (34,291) |
| Other investing activities | — | 24 |
| Net cash used in investing activities | $(10,994) | $(40,167) |

The primary outflow of cash relates to investments in property, plant and equipment as we invest in infrastructure, add to our on-demand manufacturing service and equip facilities for new product development efforts. In 2017 we acquired Vertex for an aggregate purchase price of $34.3 million, net of cash acquired.

#### Cash flow from financing activities

### Table 12

*(Dollars in thousands)*

|  | Three Months Ended March 31, 2018 | 2017 |
| --- | ---: | ---: |
| Payments on earnout consideration | $(2,675) | $(3,206) |
| Payments related to net-share settlement of stock-based compensation | (837) | (1,088) |
| Repayment of capital lease obligations | (128) | (120) |
| Net cash used in financing activities | $(3,640) | $(4,414) |

Cash used in financing activities was $3.6 million and $4.4 million for the quarters ended March 31, 2018 and 2017, respectively. The primary outflows of cash relate to payments on earnout provisions related to one of our acquisitions and the settlement of stock-based compensation.

We may issue additional securities from time to time as necessary to provide flexibility to execute our growth strategy. No securities were issued during the quarter ended March 31, 2018 and 2017.

#### Contractual commitments and off-balance sheet arrangements

#### Credit facilities

In October 2014, we entered into a $150.0 million five-year revolving, unsecured credit facility. The agreement provides for advances in the initial aggregate principal amount of up to $150.0 million. Subject to certain terms and conditions contained in the agreement, we may, at our option, request an increase in the aggregate principal amount available under the credit facility by an additional $75.0 million. As of March 31, 2018 and December 31, 2017, there was no outstanding balance on the credit facility. The credit facility contains customary covenants, some of which require us to maintain certain financial ratios that determine the amounts available and terms of borrowings and events of default. We were in compliance with all covenants at both March 31, 2018 and December 31, 2017. See Note 7 to the condensed consolidated financial statements.

#### Capitalized lease obligations

Our capitalized lease obligations include a lease agreement that we entered into during 2006 with respect to our Rock Hill, SC facility, in addition to other lease agreements assumed through acquisitions. In accordance with ASC 840, “Leases,” we are considered an owner of the properties, therefore, we have recorded these amounts in our consolidated balance sheet with a corresponding capitalized lease obligation in the liabilities section of the consolidated balance sheet. Our outstanding capitalized lease obligations carrying value at March 31, 2018 and December 31, 2017 was $7.6 million and $7.7 million, respectively.

#### Redeemable noncontrolling interests

The minority interest shareholders of a certain subsidiary have the right to require us to acquire either a portion of or all ownership interest under certain circumstances pursuant to a contractual arrangement, and we have a similar call option under the same contractual terms. The amount of consideration under the put and call rights is not a fixed amount, but rather is dependent upon various valuation formulas and on future events, such as revenue and gross margin performance of the subsidiary through the date of exercise, as described in Note 15 to the condensed consolidated financial statements. Management estimates, assuming that the subsidiary owned by us at March 31, 2018 performs over the relevant future periods at its forecasted earnings levels, that these rights, if exercised, could require us in a future period to pay a maximum amount of approximately $8.9 million to the owners of such put rights. This amount has been recorded as redeemable noncontrolling interests on the balance sheet at March 31, 2018.

#### Other contractual arrangements

We lease certain of our facilities and equipment under non-cancelable operating leases. For the quarters ended March 31, 2018 and 2017, rent expense under operating leases was $4.3 million and $3.7 million, respectively.

Certain of our acquisition purchase agreements contain earnout payment provisions under which the sellers of the acquired businesses can earn additional amounts. The total amount of liabilities recorded for these earnouts is $2.6 million and $5.1 million at March 31, 2018 and December 31, 2017, respectively.

#### Off-balance sheet arrangements

We have no off-balance sheet arrangements and do not utilize any “structured debt,” “special purpose,” or similar unconsolidated entities for liquidity or financing purposes.

### Recent Accounting Pronouncements

Refer to Note 1 - Basis of Presentation of the Notes to Financial Statements (Part I, Item 1 of this Form 10-Q) for further discussion.

### Critical Accounting Policies and Significant Estimates

Our condensed consolidated financial statements are prepared in accordance with GAAP. The preparation of these condensed consolidated financial statements requires us to make certain estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses, and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions. Our actual results may differ from these estimates under different assumptions or conditions.

Except for the accounting policies related to revenue recognition that were updated as a result of adopting ASC Topic 606, there have been no changes to our critical accounting policies and estimates described in the Annual Report on Form 10-K for the year ended December 31, 2017, filed with the Securities and Exchange Commission ("SEC") on March 14, 2018, that have had a material impact on our condensed consolidated financial statements and related notes.

### Forward-Looking Statements

Certain statements made in this Form 10-Q that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In many cases, you can identify forward-looking statements by terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates,” or “plans” or the negative of these terms or other comparable terminology.

Forward-looking statements are based upon management’s beliefs, assumptions and current expectations concerning future events and trends, using information currently available, and are necessarily subject to uncertainties, many of which are outside our control. Although we believe that the expectations reflected in the forward-looking statements are reasonable, forward-looking statements are not, and should not be relied upon as a guarantee of future performance or results, nor will they necessarily prove to be accurate indications of the times at or by which any such performance or results will be achieved. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements. These factors include without limitation:

- competitive industry pressures;
- our ability to deliver products that meet changing technology and customer needs;
- our ability to identify strategic acquisitions, to integrate such acquisitions into our business without disruption and to realize the anticipated benefits of such acquisitions;
- impact of future write-off or write-downs of intangible assets;
- our ability to acquire and enforce intellectual property rights and defend such rights against third party claims;
- our ability to protect our intellectual property rights and confidential information, including our digital content, from third-party infringers or unauthorized copying, use or disclosure;
- failure of our information technology infrastructure or inability to protect against cyber-attack;
- our ability to generate net cash flow from operations;
- our ability to obtain additional financing on acceptable terms;
- impact of global economic, political and social conditions and financial markets on our business;
- fluctuations in our gross profit margins, operating income or loss and/or net income or loss;
- our ability to efficiently conduct business outside the U.S.;
- our dependence on our supply chain for components and sub-assemblies used in our 3D printers and other products and for raw materials used in our print materials;
- our ability to manage the costs and effects of litigation, investigations or similar matters involving us or our subsidiaries;
- product quality problems that result in decreased sales and operating margin, product returns, product liability, warranty or other claims;
- our ability to retain our key employees and to attract and retain new qualified employees, while controlling our labor costs;
- our exposure to product liability claims and other claims and legal proceedings;
- disruption in our management information systems for inventory management, distribution, and other key functions;
- compliance with U.S. and other anti-corruption laws, data privacy laws, trade controls, economic sanctions, and similar laws and regulations;
- changes in, or interpretation of, tax rules and regulations; and
- compliance with, and related expenses and challenges concerning, conflict-free minerals regulations; and
- the other factors discussed in the reports we file with or furnishes to the Securities and Exchange Commission (“SEC”) from time to time, including the risks and important factors set forth in additional detail in “Risk Factors” in Part I, Item 1A of our Form 10-K filed with the SEC.

Certain of these and other factors are discussed in more detail in “Item 1A. Risk Factors” of our Form 10-K. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements included herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update or review any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or circumstances or otherwise. All subsequent written or oral forward-looking statements attributable to us or individuals acting on our behalf are expressly qualified in their entirety by the cautionary statements referenced above.

## Market risk

As filed, 323 characters.

For a discussion of market risks at December 31, 2017, refer to Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” in our Form 10-K. During the first quarter of 2018, there were no material changes or developments that would materially alter the market risk assessment performed as of December 31, 2017.

## Controls and procedures

As filed, 1,981 characters.

#### Evaluation of disclosure controls and procedures

As of March 31, 2018, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) pursuant to Rules 13a-15 and 15d-15 under the Exchange Act. These controls and procedures were designed to provide reasonable assurance that the information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures. Based on this evaluation, including an evaluation of the rules referred to above in this Item 4, management has concluded that our disclosure controls and procedures were effective as of March 31, 2018 to provide reasonable assurance that the information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, in a manner to allow timely decisions regarding required disclosures.

### Changes in Internal Controls over Financial Reporting

There were no material changes in our internal controls over financial reporting during the period covered by this Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Filed May 2, 2018.
Source: SEC EDGAR, the filing index for accession 0000910638-18-000011. Last ingested by Listed: Nov 15, 2026, 00:01 ET. No prices; not investment advice.
